In 2009, in the Active Bacterial Core surveillance sites, penicillin was not commonly used to treat meningococcal disease. This is likely because of inconsistent availability of antimicrobial susceptibility testing and ease of use of third-generation cephalosporins. Consideration of current practices may inform future meningococcal disease management guidelines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047430 | PMC |
| http://dx.doi.org/10.1093/ofid/ofw152 | DOI Listing |
Publication Analysis
Top Keywords
meningococcal disease
12
disease management
8
active bacterial
8
bacterial core
8
core surveillance
8
surveillance sites
8
penicillin meningococcal
4
management active
4
sites 2009
4
2009 2009
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!